|
Neuropathic pain medication
Abstract
The investigators discovered potent AT2 antagonists for non-addictive pain relief. Several new lead compounds displayed better potency than the previous clinical candidate EMA401 (EC50=0.16nM vs 4.9nM). All compounds tested had good solubility, acceptable hepatocyte clearance and CYP inhibition profiles, as well...
|